You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Merck
Boehringer Ingelheim
Baxter
McKesson

Last Updated: July 7, 2020

DrugPatentWatch Database Preview

Patent: 9,771,358

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,771,358
Title:Dihydropyrimidine compounds and their application in pharmaceuticals
Abstract: Provided herein are dihydropyrimidine compounds and their pharmaceutical applications, especially for use in treating and preventing HBV diseases. Specifically, provided herein are compounds having Formula (I) or (Ia), or an enantiomer, a diastereoisomer, a tautomer, a hydrate, a solvate, or a pharmaceutically acceptable salt thereof, wherein the variables of the formulas are as defined in the specification. Also provided herein is the use of the compounds having Formula (I) or (Ia), or an enantiomer, a diastereoisomer, a tautomer, a hydrate, a solvate, or a pharmaceutically acceptable salt thereof for treating and preventing HBV diseases. ##STR00001##
Inventor(s): Zhang; Yingjun (Dongguan, CN), Ren; Qingyun (Dongguan, CN), Liu; Xinchang (Dongguan, CN), Goldmann; Siegfried (Dongguan, CN)
Assignee: SUNSHINE LAKE PHARMA CO., LTD. (Dongguan, Guangdong, CN)
Application Number:15/116,226
Patent Claims:see list of patent claims

Details for Patent 9,771,358

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Hoffman-la Roche PEGASYS peginterferon alfa-2a SYRINGE 103964 002 2002-10-16   Start Trial SUNSHINE LAKE PHARMA CO., LTD. (Dongguan, Guangdong, CN) 2034-03-28 RX search
Hoffman-la Roche PEGASYS peginterferon alfa-2a VIAL; SUBCUTANEOUS 103964 001 2002-10-16   Start Trial SUNSHINE LAKE PHARMA CO., LTD. (Dongguan, Guangdong, CN) 2034-03-28 RX search
Serono Inc REBIF interferon beta-1a SYRINGE 103780 002 2002-03-07   Start Trial SUNSHINE LAKE PHARMA CO., LTD. (Dongguan, Guangdong, CN) 2034-03-28 RX search
Serono Inc REBIF interferon beta-1a SYRINGE 103780 001 2002-03-07   Start Trial SUNSHINE LAKE PHARMA CO., LTD. (Dongguan, Guangdong, CN) 2034-03-28 RX search
Biogen AVONEX interferon beta-1a VIAL 103628 001 1996-05-17   Start Trial SUNSHINE LAKE PHARMA CO., LTD. (Dongguan, Guangdong, CN) 2034-03-28 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Colorcon
Mallinckrodt
McKinsey
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.